Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine

NCT04344054 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

850

Enrollment

OTHER

Sponsor class

Conditions

Rotavirus Vaccine

Interventions

BIOLOGICAL: RV3-BB
BIOLOGICAL: Trivalent P2-VP8
BIOLOGICAL: Rotarix
BIOLOGICAL: RV3-BB birth dose
BIOLOGICAL: Trivalent P2-VP8 Booster dose

Sponsor

PATH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]